EU Grants Conditional Approval for Roche’s One-Minute Subcutaneous Lunsumio in Follicular Lymphoma Read more
Novartis Opens New Radioligand Therapy Manufacturing Facility in California to Boost U.S. Cancer Treatment Capacity Read more